Evidence map›Paper›PMID 31122171›Full record

ArticleInternational journal of stroke : official journal of the International Stroke Society2019

A national economic and clinical model for ischemic stroke care development in Saudi Arabia: A call for change.

Fahmi Al-Senani, Mohammed Al-Johani, Mohammad Salawati, Souda ElSheikh, Maha AlQahtani, Jamal Muthana, Saeed AlZahrani, Judith Shore, Matthew Taylor, Valeska S Ravest and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of stroke : official journal of the International Stroke Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fahmi Al-SenaniDepartment of Neurology, King Fahad Medical City, National Neurosciences Institute, Riyadh, Saudi Arabia.
Mohammed Al-JohaniDepartment of Neurology, King Fahad Medical City, National Neurosciences Institute, Riyadh, Saudi Arabia.
Mohammad SalawatiDepartment of Neurology, King Fahad Medical City, National Neurosciences Institute, Riyadh, Saudi Arabia.
Souda ElSheikhDepartment of Neurology, King Fahad Medical City, National Neurosciences Institute, Riyadh, Saudi Arabia.
Maha AlQahtaniDepartment of Neurology, King Fahad Medical City, National Neurosciences Institute, Riyadh, Saudi Arabia.
Jamal MuthanaDepartment of Neurology, King Fahad Medical City, National Neurosciences Institute, Riyadh, Saudi Arabia.
Saeed AlZahraniKing Fahad Hospital, Ministry of Health, Jeddah, Saudi Arabia.
Judith ShoreYork Health Economics Consortium, University of York, York, UK.
Matthew TaylorYork Health Economics Consortium, University of York, York, UK.
Valeska S RavestMedtronic Ltd, Watford, UK.ORCID 0000-0002-2199-1021
Simon EggingtonMedtronic International Trading Sárl, Tolochenaz, Switzerland.ORCID 0000-0001-8105-4040
Matthieu CucheMedtronic International Trading Sárl, Tolochenaz, Switzerland.
Heather DaviesYork Health Economics Consortium, University of York, York, UK.ORCID 0000-0003-1943-3765
Kyriakos LobotesisImperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
Jeffrey L SaverDepartment of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStroke is a significant burden in Saudi Arabia and the Saudi Ministry of Health's stroke committee has identified an urgent need to improve care.

aimThe purpose of this study was to undertake a health-economic analysis to quantify the impact of developing stroke care in the country.

methodsAn economic model was developed to assess the costs and clinical outcomes associated with an ischemic stroke care development program compared with current stroke care. Based on Saudi epidemiological data, cohorts of ischemic stroke patients enter the model each year for the first 10 years based on increasing incidence. Four treatment options were modeled including reperfusion and non-reperfusion treatments. The development scenario estimates the impact of gradually increasing uptake of more effective treatments over 10 years. Changes in the stroke care organization are considered along with resources required to increase capacity, allowing more patients to be admitted to stroke hospitals and access effective treatments.

resultsThe stroke care development program is associated with an increase in functionally independent patients and a decrease in disabling strokes compared with current stroke care. Additionally, the development program is associated with estimated cost savings of $602 million over 15 years ($255 million direct costs, $348 million indirect costs).

conclusionsThe model predicts that the stroke care development program is associated with improved patient outcomes and lower overall costs compared with the current stroke care program.

Indexed as

Models, EconomicCosts and Cost AnalysisDelivery of Health CareHumansIschemiaNational Health ProgramsPatient Outcome AssessmentReperfusionSaudi ArabiaStrokeCost analysiscost-effectivenesseconomic modelischemic strokeSaudi Arabiastroke care

Identifiers

PMID31122171
PMCPMC6823921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.